Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Why no Holocom announcements by PTSC......

cleanser / Re: Why no Holocom announcements by PTSC......fatwollit

posted on Aug 18, 2008 09:03PM

Don't forget the buyback criteria is MINIMUM of 10% of the license deals, so if bigboy Bosch paid a typical fee (following the historical average would put them in the $25M range), then PTSC could be spending up to a minimum of $1.25M just from that deal. At today's prices, that would get you about 5M shares. Take those 5M shares bought now, and if the share price were to be 75 cents at the time of the Crossflo close, and PTSC will have just saved $2.5M in doing the deal. USing these numbers just for example, but the Hoya, Bosch and Audiovox deal proceeds are NOT shown on the recent filing balance sheet, so PTSC should have at least a few million more in the bank that they haven't yet disclosed.

Share
New Message
Please login to post a reply